Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia

Journal of Korean Medical Science

Volumn 19, Issue 2, 2004, Pages 253-257

  Choi, Hyunah ^a   Kang, Ja Young ^a   Yoon, Hong Sun ^a   Han, Seung Suk ^a   Whang, Chang Sun ^a   Moon, In Gui ^a   Shin, Hyun Ho ^a   Park, Jeong Bae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Angiotensin Converting Enzyme; Angiotensinogen Genes; Genetics; Peptidyl Dipeptidase A; Pre Eclampsia

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; ASIAN; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY COMPLICATION; RESTRICTION MAPPING;

EID: 2342650664     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.2.253     Document Type: Article

References (32)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M, NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437-45.
2. Cooper DW, Hill JA, Chesley LC, Bryans CI. Genetic control of susceptibility to eclampsia and miscarriage. Br J Obstet Gynaecol 1988; 95: 644-53.
3. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344: 867-72.
4. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-6.
5. Roberts JM, Lain KY. Recent Insights into the pathogenesis of preeclampsia. Placenta 2002; 23: 359-72.
6. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel JM. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4: 59-61.
7. Arngrimsson R, Purandare S, Connor M, Walker JJ, Bjornsson S, Soubrier F, Kotelevtsev YV, Geirsson RT, Bjornsson H. Angiotensinogen: a candidate gene involved in preeclampsia? (letter). Nat Genet 1993; 4: 114-5.
8. Shim SS, Shim JY, Lim JH, Park JS, Jun JK, Bai KB, Yoon BH, Syn HC. Molecular biological approach to find out the etiology of hypertensive disorder in pregnancy: analysis of the polymorphism in the promoter of human angiotensinogen gene in Korean population. Korean J Obstet Gynecol 2003; 46: 1486-92.
9. Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW. Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese. Electrophoresis 1997; 18: 1646-9.
10. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90: 2199-202.
11. Tamura T, Johanning GL, Goldenberg RL, Johnston KE, DuBard MB. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 1996; 88: 497-502.
12. Kim DK, Kim JW, Kim S, Gwon HC, Ryu JC, Huh JE, Choo JA, Choi Y, Rhee CH, Lee WR. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 1997; 17: 3242-7.
13. Johanning GL, Johnston KE, Tamura T, Goldenberg RL. Ethnic differences in angiotensin converting enzyme gene polymorphism. J Hypertens 1995; 13: 710-1.
14. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-22.
15. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
16. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 1997; 99: 1585-95.
17. Morise T, Takeuchi Y, Takeda R. Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med 1995; 237: 175-80.
18. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235→Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993; 197: 833-9.
19. Cugini P, Letizia C, Di Palma L, Battisti P, Caserta D, Moscarini M, Scavo D. Serum angiotensin-converting enzyme activity in pre-eclamptic pregnancy: evidence for a relative hypermesorACEemia. Enzyme 1990; 43: 113-21.
20. Dux S, Yaron A, Carmel A, Rosenfeld JB. Renin, aldosterone, and serum-converting enzyme activity during normal and hypertensive pregnancy. Gynecol Obstet Invest 1984; 17: 252-7.
21. Jackson A, Brown K, Langdown J, Luddington R, Baglin T. Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 2000; 111: 562-4.
22. Langer B, Grima M, Coquard C, Bader AM, Schlaeder G, Imbs JL. Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet Gynecol 1998; 91: 196-202.
23. Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Pipkin FB, Kalsheker N. Angiotensin converting enzyme insertion-deletion polymorphism in normotensive and preeclamptic pregnancies. J Hypertens 1999; 17: 765-8.
24. Heiskanen JTM, Pirskanen MM, Hiltunen MJ, Mannermaa AJ, Punnonem KRA, Heinonen ST. Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia. Am J Obstet Gynecol 2001; 185: 600-3.
25. Rasmussen AB, Pedersen EB, Romer FK, Johannesen P, Kristensen S, Lauritsen JG, Wohlert M. The influence of normotensive pregnancy and pre-eclampsia on angiotensin-converting enzyme. Acta Obstet Gynecol Scand 1983; 62: 341-4.
26. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, Ganten D, Dzau VJ, Lander ES. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991; 67: 213-24.
27. Hubert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S, Vincent M, Ganten D, Georges M, Lathrop GM. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 1991; 353: 521-9.
28. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, Genuardi M, Abbate R, Fatini C. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 2003; 41: 932-7.
29. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, Marcucci R, Brunelli T, Mello G, Parretti E, Pepe G, Abbate R. Angiotensin converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis 2000; 11: 657-62.
30. Roh CR, Kim DK, Yoon BK, Yang SH, Chung JH, Bae DS, Lee JH. A common genetic variant of the angiotensin converting enzyme (ACE) gene and pregnancy induced hypertensive disorders. Korean J Obstet Gynecol 1997; 40: 1189-99.
31. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.
32. August P, Sealey JE. The renin-angiotensin system in normal and hypertensive pregnancy and in ovarian function. In: Lahagh JH, Brenner BM, editors, Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press, 1990; 1761-78.